Sevin, Caroline
Hatteb, Samira
Clément, Aurore
Bignami, Fabrizia
Chillotti, Louis
Bugnard, Françoise
Bénard, Stève
Boespflug-Tanguy, Odile
Funding for this research was provided by:
bluebird bio (bluebird bio)
Article History
Received: 3 October 2022
Accepted: 23 July 2023
First Online: 10 August 2023
Declarations
:
: Data are issued from the French National Health Insurance information system with agreement from the French National Data Protection Agency. The study protocol was approved on June 13, 2019, by the Expert Committee for Healthcare Data Research. During their inclusion in LEUKOFRANCE registry, patients or legal guardian signed a consent form for their data to be used.
: Not concerned.
: CS has no conflict of interest to be disclosed. SH has no conflict of interest to be disclosed. AC has been employed by bluebird bio during this study and until October 2021. FBi has been employed by bluebird bio during this study and until January 2022. LC and FBu are employees of stève consultants, which has a research consultancy contract with Bluebird Bio. SB is the executive director of stève consultants, which has a research consultancy contract with Bluebird Bio. OBT has no conflict of interest to be disclosed.